Wednesday, 5 August 2026
HOLAFLY IDENTIFIES TOP INTERNATIONAL ALTERNATIVES TO ICONIC DESTINATIONS
According to Holafly in a statement, destinations such as Venice, Aspen, Kyoto and Ibiza remain enduringly popular, but travellers are increasingly seeking comparable scenery and cultural experiences without the crowds, queues and higher prices associated with major tourist hotspots.
Unlike traditional "dupe" rankings, every alternative in the index is located in a different country from the destination it replaces, allowing travellers to discover a genuinely new destination while retaining a similar atmosphere and appeal.
The study found that the strongest alternative to Venice is Ghent, Belgium, whose mediaeval canals and historic architecture offer a similar experience while facing significantly lower tourism pressure.
The ranking also highlights Banff, Canada, as an alternative to Aspen, United States; Jeonju, South Korea, instead of Kyoto, Japan; and Budva, Montenegro, instead of Ibiza, Spain, with travellers saving up to 83 per cent on accommodation costs, depending on the destination.
Holafly said international travel dupes are emerging as an alternative to overtourism, enabling visitors to enjoy similar landscapes, architecture and cultural experiences while reducing travel costs and avoiding peak visitor numbers.
To compile the index, Holafly compared 10 iconic destinations with international alternatives using a weighted scoring model. The destinations were assessed based on visual and cultural similarity, accommodation savings, overtourism contrast, accessibility, and social momentum, including social media and online search trends.
The company added that each alternative had to be located in a different country from the original destination, with the methodology designed to highlight destinations that offer similar experiences, better value and fewer crowds while encouraging travellers to discover new places.
-- BERNAMA
Wednesday, 29 July 2026
The a2 Milk Company Advances Global Leadership in Beta-Casein Science with New Research Presented at NUTRITION 2026
- The a2 Milk Company presented new clinical and preclinical research at NUTRITION 2026, the American Society for Nutrition’s annual meeting held July 25-28 in National Harbor, Maryland.
- The research program included two studies presented by The a2 Milk Company and company-funded studies led by investigators at Purdue University and Nova Southeastern University.
- Together, the studies examined infant growth and safety, protein utilization, digestive tolerance, gastrointestinal biomarkers and the gut-brain axis, building on more than two decades of research in A1- and A2-type beta-casein protein.
AUCKLAND, New Zealand, July 29 (Bernama-GLOBE NEWSWIRE) -- The a2 Milk Company today announced new clinical and preclinical research presented at NUTRITION 2026, the annual meeting of the American Society for Nutrition. The studies examined infant growth and safety, protein utilization and gastrointestinal biomarkers, and the respective roles of lactose and beta-casein in digestive tolerance.
The presentations included two studies from The a2 Milk Company and company-funded research conducted by Purdue University and Nova Southeastern University investigators. They add to the company’s research program focused on naturally occurring beta-casein variants and their potential effects on digestion and health.
New Research Highlights
New Clinical Study Demonstrates Safety and Growth of Infant Formula Made with Milk Free from A1 Beta-Casein
The a2 Milk Company presented results from a randomized, double-blind controlled trial evaluating the growth and safety of infant formula made with milk free from A1-type beta-casein protein (A1PF) in healthy term infants.
The Growth Monitoring Study, a clinical trial required by the U.S. Food and Drug Administration (FDA) for new infant formulas, demonstrated that infants fed A1PF formula experienced normal growth throughout the 16-week study period, meeting the FDA's predefined non-inferiority criteria when compared with a commercially available infant formula.
Beyond meeting the study's primary endpoint, additional analyses found that infants receiving the A1PF formula:
- Achieved significantly greater average weight gain (3,577.78 vs. 3,376.50grams), compared with those receiving conventional formula – approximately 6% greater weight gain
- Demonstrated significantly greater length gain (12.88 vs. 12.08 cm) compared with infants fed conventional formula – approximately 6.6% greater length gain
- Had significantly higher weight-for-age and length-for-age z-scores at 16 weeks.
New Preclinical Study Examines Protein Efficiency and Gastrointestinal Biomarkers
Research presented by Armstrong examined the protein component of an infant formula made with A1PF milk using the Association of Official Analytical Collaboration (AOAC INTERNATIONAL) Protein Efficiency Ratio (PER) Official Method 960.48.
Key findings included:
- Higher adjusted PER compared with casein controls
- Elevated antioxidant status
- Reduced gastrointestinal inflammatory markers
- Improved intestinal barrier function markers
- Higher lactase gene and protein expression
Purdue University Researchers Advance Understanding of Milk Protein and Digestive Health i
Purdue University investigators independently conducted the research, with funding provided by The a2 Milk Company. The studies examined the role of A1- and A2-type beta-casein in digestion and metabolism, further contributing to the growing body of scientific evidence on milk protein biology.
Purdue investigators also presented additional research exploring the biological mechanisms underlying A1- and A2-type beta-casein, including studies on gastric emptying, glucose metabolism, and redox biology.
"Our goal is to better understand the factors that contribute to dairy tolerance and digestive health," said Dennis A. Savaiano, Ph.D., Professor of Nutrition Science at Purdue University. "These studies advance our understanding of how naturally occurring differences in milk proteins may influence digestive physiology and metabolic responses, while highlighting the importance of continued clinical research to better understand these complex interactions."
Nova Southeastern University Researchers Examine Links Between Milk Protein Type and Inflammation Markersii
Researchers at Nova Southeastern University independently conducted the research, with funding provided by The a2 Milk Company. Led by neuroscientist Dr Richard Deth, the study explored how naturally occurring differences in milk proteins may influence inflammation in the gut and brain.
"These findings provide new insight into how a natural variation exhibited by a milk protein may influence communication between the gut and brain," said Richard Deth, Ph.D., Professor of Pharmaceutical Sciences at Nova Southeastern University. "Understanding these biological pathways helps advance our knowledge of the relationship between nutrition, inflammation and cognitive function.
Building on More Than Two Decades of Scientific Leadership
The NUTRITION 2026 presentations build upon an expanding body of clinical and preclinical evidence examining the differences between A1- and A2-type beta-casein proteins.
Research conducted over the past two decades has shown that milk free from A1-type beta-casein has been associated with improved digestive comfort and reduced gastrointestinal symptoms, lower markers of inflammation, higher antioxidant levels, specifically in individuals with lactose intolerance, and emerging benefits for cognition and quality of life in older adults.
Unlike conventional milk, milk free from A1-type beta-casein does not preferentially release the peptide beta-casomorphin-7 (BCM-7) during digestion, a proposed mechanism that researchers continue to investigate as part of understanding digestive and physiological differences between beta-casein protein types.
"For more than two decades, The a2 Milk Company has invested significantly in in vitro, pre-clinical and clinical studies to bring us to the level of understanding we now have," said Dr. Andrew Clarke, Chief Scientific Advisor at The a2 Milk Company. "The research presented at NUTRITION 2026 reflects our long-standing commitment to advancing research into A1 protein free dairy and helping expand the evidence base for healthcare professionals, researchers and consumers worldwide."
About The a2 Milk Company
The a2 Milk Company is a dairy nutrition company that develops products made with milk containing only the A2-type beta-casein protein. For more than 25 years, the company has worked alongside scientists around the world to advance understanding of beta-casein protein science.
The company has products and trading activities across New Zealand, Australia, Greater China, North America and selected emerging markets. Its infant nutrition products are available in key international markets, including China, Australia and Vietnam.
For more information, visit The a2 Milk Company website.
Contact
Katie Pawelczyk, MS, RD
Kpawelczyk@foodminds.com
__________________________________
i Sujani S, Mysore Saiprasad S, Dong J, Deth R, Eaton T, Savaiano, DA. Differential Effects of Lactose-Free A1/A2 Versus A2/A2 Milk on Digestive Discomfort and Gut Inflammation in Adults with Perceived Dairy Intolerance. Poster Presented at: NUTRITION 2026, American Society for Nutrition Annual Meeting; July 25-28, 2026; National Harbor, MD. Poster No. E-94
ii Deth R, Rose N, Dong J, Eshraghi R, Armstrong K, Blum J, Ridling E, Clarke A. A Novel Gut-Brain Connection: Differential Influence of Conventional vs. A1 Protein-free Milk Consumption on Inflammation-Related Gene Expression. Poster presented at: NUTRITION 2026, American Society for Nutrition Annual Meeting; July 25-28, 2026; National Harbor, MD. Poster No. E-16
SOURCE: THE A2 MILK COMPANY LIMITED
HOTEL OKURA TO OPEN LUXURY CAPPADOCIA RESORT IN 2028
![]() |
| Rendition of Hotel Okura Thermal Resort & Spa Cappadocia |
KUALA LUMPUR, July 28 (Bernama) -- Hotel Okura Co Ltd, a global Japanese hotel operator, has announced that the Hotel Okura Thermal Resort & Spa Cappadocia is scheduled to open in 2028 in the historic village of Mustafapaşa in the Cappadocia region of Türkiye.
Building on the initial Okura Spa & Resort Cappadocia project announced in June 2015, the development is moving forward in collaboration with Hotel Okura's new partner, KK Universal, a real estate and hospitality investment group headquartered in Türkiye.
The site has been expanded to create a luxury resort. The new plans feature premier thermal and wellness facilities that blend Okura's signature omotenashi (Japanese-style hospitality) with the unique cultural heritage of the Cappadocia region.
On May 22, Hotel Okura signed a hotel management contract with Oluşum Grubu Gayrimenkul Yatırımları ve İnşaat Ticaret A.Ş., a hotel operating company backed by KK Universal.
In a statement, the hotel said the property will be operated by Okura Saraylı Hotel Management A.Ş., a joint venture established in February 2015 between Hotel Okura Co Ltd and local partners Saraylı Turizm A.Ş. and MSIC Gayrimenkul Yatırım ve Danışmanlık Ticaret Ltd Şti.
According to Hotel Okura, the resort will comprise four buildings, including preserved historic stone structures and newly constructed facilities, three of which are connected by underground passages.
The design of the property will harmonise with Mustafapaşa's distinctive charm and architectural character, offering guests an authentic experience infused with Okura's refined aesthetic and omotenashi hospitality.
The resort will also showcase Türkiye's renowned thermal culture through comprehensive wellness experiences, featuring a 3,500-square-metre spa and wellness centre with thermal baths, as well as indoor and outdoor pools.
The dining experience will also feature three venues, including the internationally acclaimed teppanyaki restaurant "Sazanka", and an all-day dining establishment.
-- BERNAMA
Wednesday, 22 July 2026
Bitget Launches Industry-First Quanto Perpetual Futures for TradFi Assets
The contract prices the underlying stock in its local currency, HKD for Hong Kong equities or JPY for Japanese equities, but settles margin, funding fees, and realized P&L entirely in USDT. The system treats the local-currency price as numerically equivalent to USDT at 1:1, so the contract's price movement matches the underlying stock exactly, without any fiat involvement.
"Quanto contracts are not new in crypto derivatives, but no major exchange has applied the structure to traditional financial assets until now," said Gracy Chen, CEO at Bitget. "From Pre-IPO access to US stock options, we are building a trading environment where crypto infrastructure serves global financial markets. The Quanto contracts remove the last barrier for global traders: currency conversion. Anyone holding USDT can now trade Hong Kong and other non-USD stocks as easily as they trade Bitcoin. This is convergence in practice which Bitget has been able to crack."
The problem the product solves is straightforward. A user who wants to buy Hong Kong stocks in HKD normally has to convert USDT to HKD first, taking on exchange rate risk on both the position and the conversion itself. Bitget's quanto structure removes that step. A trader opening a long position of 10 MINIMAXHKDUSDT contracts at 30 and closing at 50 earns 200 USDT, calculated as (50 minus 30) times 10, settled directly to the futures account. No forex conversion happens at any point.
The launch lands in a market that is growing fast. TokenInsight's Crypto Exchange Report Q2 2026 found that TradFi perpetuals were the fastest-growing segment across the crypto exchange industry in the quarter. Monthly volume expanded from roughly $52 billion in January to $268 billion in June, a fivefold increase over the first half of the year, with equity perpetuals overtaking commodities as the primary growth driver. Bitget was one of the fastest-growing platforms in the sector. The exchange generated approximately $69 billion in TradFi perpetual volume during Q2, capturing 11.01% market share and ranking second among all exchanges.
The quanto launch follows a year of product firsts that have made TradFi a core part of Bitget's business rather than a side feature. The exchange introduced tokenized stock perpetual contracts offering synthetic exposure to publicly traded companies with USDT settlement and up to 100x leverage, then added CFD trading in late 2025 for access to global equities, commodities, and forex through stablecoin settlement. In April 2026, Bitget launched IPO Prime, the industry's first Pre-IPO trading service, powered by Republic, giving users exposure to private companies such as SpaceX before public listing. In July, Bitget became the only major crypto exchange offering US stock options, with long call and long put strategies on US-listed equities alongside crypto and CFD markets.
The MINIMAXHKD Quanto Perpetual Contracts is now live on Bitget and supports up to 20x leverage, 24/7 trading, and funding rate settlement every 8 hours. To know more visit here.
About Bitget
Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.
For more information, visit: Website | X | Telegram | LinkedIn | Discord
For media inquiries, please contact: media@bitget.com
Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/886dfb0b-711a-4231-9cb4-29d5710d3ec1
DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.
Friday, 17 July 2026
MODON, NAMMOS LAUNCH LUXURY EGYPT DESTINATION
KUALA LUMPUR, July 17 (Bernama) -- Abu Dhabi-based Modon Holding and Nammos Hotels & Resorts have unveiled Nammos Ras El Hekma, the hospitality brand's first fully integrated destination in Egypt, as part of the US$35 billion Ras El Hekma masterplan on the country's North Coast. (US$1=RM4.07)
Located within the Wadi Yemm precinct, the development will comprise Nammos Residences, Nammos Resort, Nammos Village, and the Nammos Restaurant & Beach Club, alongside wellness, retail and leisure facilities designed to offer a Mediterranean-inspired lifestyle.
Nammos Residences will feature 72 apartments and a penthouse, while Nammos Resort will offer 79 hotel keys across five accommodation categories. Residents and visitors will have access to hospitality, wellness and recreational amenities within the emerging coastal city.
Modon Holding Group Chief Executive Officer (CEO), Bill O'Regan said Ras El Hekma is rapidly emerging as one of the Mediterranean's most ambitious destinations, adding that the project strengthens the company's vision of developing a year-round city offering world-class living, leisure and investment opportunities.
Meanwhile, Nammos Chairman, Petros Stathis said the launch marks a significant milestone in the brand's global expansion strategy, describing Egypt's North Coast as an ideal location to extend the Nammos brand.
Nammos Hotels & Resorts CEO, Carolyn Turnbull said the destination has been designed to seamlessly integrate hospitality, residences and lifestyle experiences while reflecting the energy and identity that have defined the Nammos brand for more than two decades.
Nammos Ras El Hekma forms part of the 170.8 million square metre Ras El Hekma masterplan, which is expected to attract US$110 billion in investment by 2045, according to a statement.
Wadi Yemm is the first of the development's 17 precincts to enter the delivery phase, with the wider project planned as a mixed-use city featuring residential, commercial, tourism and cultural districts supported by road, sea and air connectivity.
-- BERNAMA
Wednesday, 8 July 2026
NOTICE TO DISREGARD -- COMPUTESHARE PTE. LTD.
SINGAPORE, July 8 (Bernama-GLOBE NEWSWIRE) -- We are advised by COMPUTESHARE PTE. LTD. that journalists and other readers should disregard the news release, "COMPUTESHARE PTE. LTD. Launches Global Membership Ecosystem" issued July 06, 2026, over GlobeNewswire.
SOURCE: COMPUTESHARE PTE. LTD.
Monday, 6 July 2026
COMPUTESHARE PTE. LTD. Launches Global Membership Ecosystem
Mature T3+T4 Infrastructure Supports China Regional Closed Beta Scheduled for July 16
SINGAPORE, July 6 (Bernama-GLOBE NEWSWIRE) -- Recently, Singapore-based COMPUTESHARE PTE. LTD. announced the launch of its global membership ecosystem, with the first closed beta in the China regional market scheduled for July 16, 2026. Operating under the business brand Computershare Singapore, the project has established two core divisions: Enterprise AI Customization Services and the Global Membership Ecosystem.
Computershare was founded in Melbourne, Australia, in 1978 and has extensive experience in corporate services, data management, large-scale transaction processing and global operations. This experience supports the project’s digital platform development, data recording systems and international operations.
Enterprise AI Customization Services serve large enterprises, brands, e-commerce service providers and digital marketing organizations, offering enterprise knowledge bases, AI customer service, batch product image and video production, digital humans, multilingual content, AI Agent workflows and long-term technical support.
The company has established partnerships with multiple businesses in Singapore and other regions. These collaborations cover AI-powered product content factories, TikTok content production, digital humans, product asset creation, multilingual localization, brand knowledge base development, and intelligent customer service.
The company’s T3+T4 computing and core data infrastructure is operating in a mature and stable production environment. The T3 GPU zone supports high-frequency workloads such as AI images, short videos, digital humans, knowledge base inference, AI customer service and e-commerce content. The T4 zone handles core task scheduling, critical data storage, task records, settlement records, contribution records and long-term digital archives.
The global membership ecosystem will operate around computing quotas, computing allocations, AI task participation, task rotation, cumulative completed task volume, CSC contribution records, member development and regional service networks. Actual tasks are executed through GPU resources centrally scheduled by the platform.
The China regional closed beta will cover the member-facing APP, account system, computing quotas, computing allocations, task records, CSC contribution records, service provider management and regional service networks. Following the establishment of a mature operating model, the system will gradually expand into Southeast Asia and other international markets.
Company: COMPUTESHARE PTE. LTD.
Contact Person: Ruijin Xiong
Email: cssg@computershare.com
Website: https://www.computershare.com
Telephone: +61 (0)3 9415 4000
ADD: Singapore
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/7505da6d-150d-4e8e-a790-4a67de65f612
https://www.globenewswire.com/NewsRoom/AttachmentNg/6b7841f0-7b94-46f2-b8cc-142754dbc981
https://www.globenewswire.com/NewsRoom/AttachmentNg/a06bede7-8699-41ef-8592-7b3d8c38c712
SOURCE: COMPUTESHARE PTE. LTD.
Thursday, 2 July 2026
AGC Biologics, Pyramid Pharma Services To Provide Integrated Manufacturing Solution
KUALA LUMPUR, July 1 (Bernama) -- AGC Biologics, a global biopharmaceutical contract development and manufacturing organisation (CDMO), has partnered with Pyramid Pharma Services to provide an integrated United States (US)-based manufacturing solution for drug developers.
The collaboration combines AGC Biologics' expertise in drug substance development and manufacturing with Pyramid's sterile fill-finish capabilities, providing developers with a fully integrated supply chain solution.
“We are always listening to our customers’ needs and responding with solutions that help them meet their goals. With this US-based fill-finish option, our Seattle site is well-positioned for developers that desire or even require end-to-end production in the US,” said AGC Biologics Chief Business Officer, Christoph Winterhalter.
Clients will gain access to comprehensive sterile fill-finish capabilities in the US, including liquid and lyophilised vials, pre-filled syringes and cartridges, as well as device assembly, labelling and secondary packaging services.
By combining AGC Biologics' expertise with Pyramid's experience in sterile drug product manufacturing, the partnership provides a seamless pathway from early development to commercial supply.
According to AGC Biologics in a statement, the integrated offering reduces project complexity and handoffs through centralised project management, enabling faster delivery of therapies to patients.
The new offering complements AGC Biologics' existing European fill-finish capabilities, providing clients with greater geographic flexibility and a robust US-based option to help navigate tariff exposure and strengthen supply chain security.
Pyramid Pharma Services brings nearly four decades of experience in sterile injectable drug product development, including 26 years in good manufacturing practice (GMP) manufacturing and over a decade of commercial supply, supported by a strong track record in quality, reliability and regulatory excellence.
-- BERNAMA
Thursday, 25 June 2026
Behind the Performance: Hawaii Theatre Center Subject of New Documentary
HONOLULU, June 25 (Bernama-GLOBE NEWSWIRE) -- The historic Hawaii Theatre Center — lauded as the “Pride of the Pacific” upon its opening over a century ago — has released a new documentary-style video highlighting the history, community impact, and urgent financial challenges facing one of Hawaii’s most treasured cultural institutions.
"The Hawaii Theatre is more than a venue—it's a gathering place, an educational resource, and a living piece of Hawaii's history," said Hawaii Theatre President and CEO Gregory Dunn. "This video tells the story of the people who make this institution special and why preserving it matters for future generations."
The eight-minute film features interviews with Dunn, longtime staff members, and community supporters, offering viewers a behind-the-scenes look at the 103-year-old landmark and the role it plays in preserving arts, culture, and education in Hawaii.
The video comes as the nonprofit theatre confronts a perfect storm of financial pressures, including a five-fold increase in property insurance costs following the Lahaina wildfires, declining tourism, and rising maintenance expenses associated with preserving a historic building.
“Coming out of Covid, where we were essentially shut down for 22 months, we have not fully financially recovered from that,” Dunn explains in the video. “For a non-profit that’s operating on a very thin line, this is not sustainable.”
The Hawaii Theatre’s most dire financial need relates to property insurance premiums, which recently exploded from $90,000 per year to $450,000, compounding the financial difficulties associated with maintaining and repairing a century-old building that was hit hard by recent natural disasters.
The Hawaii Theatre receives no city or state subsidies, which is why local philanthropists Nicole and Clark Swalm stepped in to help. The Swalms provided a $150,000 lead grant, which the theatre is leveraging to raise the remaining $300,000 from supporters in the Honolulu community and beyond.
“Really, it’s going to come down to the community members making choices about what they want to see in their community,” Dunn says. “We have to make the choice now because once it’s gone, it’s gone.”
The video is available now at https://www.youtube.com/watch?v=kDxutf_WuMc.
For more information or to support the Hawaii Theatre Center, visit www.HawaiiTheatre.com/support.
A video accompanying this release is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/5478d734-937c-4698-b411-6afeab8163b1
Contact:
Ron McDaniel
Director of Communications and Marketing
ronmcdaniel@hawaiitheatre.com
SOURCE: Hawaii Theatre Center
--BERNAMA
Friday, 12 June 2026
EAACI CHAMPIONS VISION ZERO TO REDUCE ALLERGY, ASTHMA BURDEN
KUALA LUMPUR, June 12 (Bernama) -- The European Academy of Allergy and Clinical Immunology (EAACI) is calling for a new global health ambition through Vision Zero, a future free from the burden of allergy and asthma.
As allergic diseases continue to affect hundreds of millions of people worldwide and place growing pressure on healthcare systems, this vision will serve as the central theme of the four-day EAACI Annual Congress 2026 in Istanbul, Türkiye, beginning June 12.
The congress will bring together thousands of clinicians, researchers and healthcare professionals to discuss the latest scientific advances and the future of allergy and asthma care, according to EAACI in a statement.
“Vision Zero reflects our determination to move beyond disease management and towards disease prevention and burden reduction. Through collaboration across research, clinical practice and public health, we can work towards a future where allergy and asthma no longer limit the lives of millions,” said EAACI President, María Torres.
EAACI believes scientific innovation, prevention strategies and coordinated policy action can significantly reduce the impact of allergic and respiratory diseases on individuals, families and societies rather than accepting them as an inevitable and growing public health challenge.
The congress will showcase emerging research and clinical developments in immunotherapy, environmental and genetic factors, digital health technologies, precision medicine and preventive approaches. Discussions will also address health equity and the need to ensure that advances in allergy and asthma care are accessible to patients worldwide.
Allergic diseases are among the most common chronic conditions globally, and their burden extends beyond healthcare to affect education, productivity, quality of life and mental wellbeing.
Against this backdrop, EAACI's Vision Zero initiative seeks to encourage long-term thinking about what is possible when scientific discovery is matched by effective implementation and policy support. The congress is expected to bring together experts worldwide to accelerate progress towards substantially reducing the burden of allergy and asthma.
-- BERNAMA
Bitget CFD Rolls Out Zero-Fee Mode Amid Daily Volume Growth Toward $10B
VICTORIA, Seychelles, June 11 (Bernama-GLOBE NEWSWIRE) -- Bitget, the world’s largest Universal Exchange (UEX), today announced the launch of Zero-Fee Mode for Bitget CFD, introducing a commission-free account option designed to make CFD trading more flexible, transparent, and accessible.
The launch comes as Bitget CFD continues to scale rapidly, with daily trading volume reaching $8 billion in May and moving closer to the $10 billion milestone. This growth reflects rising demand for multi-asset trading access, as users increasingly seek efficient ways to trade global markets within a unified platform.Bitget CFD now offers a dual-account structure that gives users greater control over how they trade. The existing ECN Mode remains available for professional, short-term, and high-frequency traders who prefer tighter spreads with volume-based commissions, while the new Zero-Fee Mode is designed for users who favor a more straightforward cost structure with standard spreads and no trading commissions.
The update is driven by growing user demand and feedback around more intuitive trading experiences. Rather than imposing a single model, Bitget CFD now gives users the flexibility to choose the account type that best matches their capital size, trading strategy, experience level, and personal preferences.
“Multi-asset access is becoming the new standard for trading platforms, and CFD is central to how Bitget is delivering that future,” said Gracy Chen, CEO of Bitget. “By introducing Zero-Fee Mode, we are providing users with greater flexibility to engage in global markets, further advancing our mission to make financial opportunities more accessible within a single, integrated ecosystem.”
This introduction follows a string of successes for Bitget CFD, including its debut industry honor as the Best Global Multi-Asset Trading Platform at the Online Trading Expo. Previously, the platform noted that non-crypto assets accounted for up to 40% of trading activity on certain days this year. Gold and U.S. indices, such as the NAS100, remain the platform’s two most popular trading products, driving overall volume growth.
Within Bitget’s UEX vision, Bitget CFD plays a key role in connecting crypto and traditional market access through one integrated trading ecosystem. The addition of Zero-Fee Mode strengthens Bitget’s broader effort to make multi-asset trading more accessible, flexible, and aligned with different user needs.
For more information about the launch, visit here.
About Bitget
Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 100+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships with LALIGA and MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.
For more information, visit: Website | Twitter | Telegram | LinkedIn | Discord
For media inquiries, please contact: media@bitget.com
Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bcc77153-f7cf-40a5-8e4a-10979c9f2206
SOURCE: Bitget Limited
DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.
--BERNAMA
Monday, 8 June 2026
CLASSICO EXPANDS POKEMON-THEMED MEDICAL APPAREL COLLECTION ACROSS ASIA
KUALA LUMPUR, June 8 (Bernama) -- Classico Inc, a Japanese medical apparel brand, has launched the #ClassicoPokemonCollection across Asia, including Singapore, Malaysia, the Philippines, Hong Kong, Taiwan and Thailand.
The collection was introduced on June 4 following strong demand from international customers after its initial launch in Japan.
Designed for healthcare professionals, the collection features Pokemon-inspired medical scrubs incorporating design elements based on Pikachu, Eevee, Snorlax and the first partner Pokemon from the Kanto region – Bulbasaur, Charmander and Squirtle.
According to Classico in a statement, the scrubs incorporate colours and embroidery inspired by the featured Pokemon, with the aim of creating a sense of comfort and approachability for patients during examinations and treatments.
The unisex collection is available in sizes ranging from XXS to XL across participating Asian markets, with pricing varying by country.
Classico specialises in medical apparel and designs products that combine functionality with professional styling for healthcare workers.
-- BERNAMA
Thursday, 4 June 2026
Onimusha: Way of the Sword Set to Release on September 25, 2026!
![]() |
| Onimusha: Way of the Sword key art |
– A playable demo will be released ahead of the game’s launch –
OSAKA, Japan, June 4 (Bernama-BUSINESS WIRE) -- Capcom Co., Ltd. (TOKYO:9697) today announced that Onimusha: Way of the Sword, the latest title in the Onimusha series, is scheduled for release on September 25, 2026.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20260603903549/en/
Onimusha: Way of the Sword, which marks the first new title in the series in over 20 years, is a Japanese-inspired dark fantasy game that features Miyamoto Musashi as the protagonist and is set in an Edo-era Kyoto that has been twisted by malevolent clouds of Malice. Capcom is developing the title with the aim of appealing to a wide range of players through its exhilarating sword-based action and highly-unique characters.
Ahead of launch, the company released a playable demo today*, June 3, 2026, titled Onimusha: Way of the Sword DEMO, to give players an opportunity to enjoy the appeal of the game as early as possible. In this demo, players can experience a variety of action-packed swordplay, including the fight against the formidable foe, Sasaki Ganryu. Further, the company also started accepting pre-orders for the title. As a pre-order bonus, players can receive equipment that can be used in the game.
In addition to regularly releasing major new titles each year, Capcom is focusing on re-activating IPs that haven’t had a new title launch recently. The company is working to further maximize corporate value by leveraging its rich library of content, including this title.
* The Windows version is scheduled to be released at a later date.
About the Onimusha series
The Onimusha series consists of swordplay action games where players assume the role of warriors with the superhuman powers of the Oni and fight against monsters bent on world domination. Cumulative game sales since the first game was released in 2001 exceed 9.1 million* units.
* As of March 31, 2026
ABOUT CAPCOM
Capcom is a leading worldwide developer, publisher and distributor of interactive entertainment for game consoles, PCs, handheld and wireless devices. Founded in 1983, the company has created hundreds of games, including groundbreaking franchises Resident Evil™, Monster Hunter™, Street Fighter™, Mega Man™, Devil May Cry™ and Ace Attorney™. Capcom maintains operations in the U.S., U.K., Germany, France, Hong Kong, Taiwan, Singapore and Tokyo, with corporate headquarters located in Osaka, Japan. More information about Capcom can be found at https://www.capcom.co.jp/ir/english/
View source version on businesswire.com:
https://www.businesswire.com/news/home/20260603903549/en/
Contact
Capcom Public Relations & Investor Relations Section
+81-6-6920-3623
Source : Capcom Co., Ltd.
--BERNAMA
Friday, 22 May 2026
FIDO Alliance Unveils Agenda For Authenticate APAC 2026 In Singapore
KUALA LUMPUR, May 21 (Bernama) -- The FIDO Alliance has announced agenda themes and programme highlights for Authenticate APAC 2026, scheduled to take place from June 2 to 3 at the Grand Hyatt Singapore.
The inaugural Asia-Pacific (APAC) conference will bring together industry leaders to discuss developments in authentication and digital identity, including passkeys, artificial intelligence (AI), digital credentials, enterprise authentication deployments and regional regulatory trends.
According to the alliance in a statement, the conference builds on seven years of Authenticate events in the United States and two years of APAC regional summits.
The event is supported by the Cyber Security Agency of Singapore, alongside signature sponsors Google, Visa and Yubico.
FIDO Alliance President, FIDO Board Representative for Google, and Google Principal Product Manager, Sam Srinivas said the APAC region has played a key role in driving adoption of passkeys and related authentication technologies.
Topics to be discussed include authentication standards, AI-driven authentication, agentic commerce, digital wallets and payment systems, enterprise passkey deployment, and emerging authentication use cases.
In addition to keynote presentations and breakout sessions, attendees will have opportunities to connect with peers and industry experts through networking events, a gala dinner, and an active expo hall.
-- BERNAMA
Thursday, 21 May 2026
I Squared Capital Launches Cube Grid – A New Power Transmission Platform in India
NEW DELHI & MIAMI, May 21 (Bernama-BUSINESS WIRE) -- I Squared Capital ("I Squared"), a leading global infrastructure investment manager, today announced the launch of Cube Grid, a new power transmission platform targeting India's rapidly expanding electricity grid. I Squared expects to deploy up to USD $1 billion of equity capital into Cube Grid to acquire and build a scaled portfolio of high-quality transmission assets across India.
Consistent with I Squared's platform-building approach, Cube Grid has signed definitive agreements for seed assets totaling more than 1,450 circuit kilometers (ckm) of transmission lines. These projects are being developed in partnership with Dineshchandra Group (Dineshchandra R. Agrawal Infracon Private Limited or "DRAIPL"), an established infrastructure developer with over five decades of experience delivering large-scale projects across India, Australia, West Asia, and Africa.
We anticipate India's power transmission sector to enter a phase of unprecedented growth, driven by strong policy support and the rapid expansion of renewable energy capacity. The Government of India has outlined an ambitious roadmap to modernize and expand the national grid, requiring an estimated USD $120 billion of capital expenditure over the next five to seven years to integrate new generation capacity and meet rising demand. We believe that this has potential of creating a significant pipeline of transmission projects across the country – compelling opportunities for both greenfield development and the acquisition of operating assets.
Harsh Agrawal, Senior Partner at I Squared Capital, said: "India is one of the fastest-growing major economies and a highly attractive infrastructure market. I Squared has been an investor in India for over a decade and has seen first-hand the rapid expansion of power generation, particularly renewables. We believe this creates a multi-decade opportunity to acquire and build critical grid assets that enable economic growth, enhance energy security, and accelerate the energy transition. DRAIPL has a proven track record from our work together on Cube Highways, another I Squared portfolio company in India. Extending this relationship to the transmission sector gives Cube Grid a strong execution partner."
Hardik Agrawal, Director at Dineshchandra Group, said: "India's transmission sector is at an inflection point as the country accelerates renewable integration and grid expansion. We are pleased to partner with I Squared and Cube Grid in developing this sector. Having witnessed I Squared's long-term, platform-oriented approach, we believe this partnership combines financial discipline and operational focus with strong execution capabilities to build high-quality transmission infrastructure and contribute to an Atmanirbhar and Viksit Bharat."
Over the past decade, I Squared has committed more than USD $4 billion to Indian infrastructure, owning, building and operating a portfolio of six companies providing essential services to millions of people across the country. The partnership with DRAIPL combines I Squared's global investment expertise and platform-building experience with DRAIPL's local execution capabilities and regional market knowledge.
The transaction is expected to close in the third quarter of 2026, subject to customary regulatory approvals and closing conditions.
About I Squared Capital
I Squared Capital is a leading independent global infrastructure investor dedicated to the mid-market, managing $55 billion in assets. Founded in 2012, I Squared has evolved into one of the most diverse infrastructure investors in the world, with investments across power & utilities; transportation & logistics; digital infrastructure; environmental infrastructure; and social infrastructure, providing essential services to millions of people worldwide. Today, the portfolio includes over 100 companies operating in more than 70 countries. Headquartered in Miami, the firm has offices in Abu Dhabi, London, Munich, New Delhi, São Paulo, Singapore, Sydney and Taipei. Learn more at www.isquaredcapital.com.
Disclaimers
This document does not constitute advice or a recommendation or offer to sell or a solicitation to deal in any security or financial product. It is provided for information purposes only. Investing involves risk; loss of principal is possible. Specific investments described herein do not represent all investment decisions made by ISQ. The reader should not assume that investment decisions identified and discussed were or will be profitable. Specific investment advice references provided herein are for illustrative purposes only and are not necessarily representative of investments that will be made in the future.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260520821733/en/
Contact
Media Contacts
I Squared Capital
Dominic McMullan / Sofie Brewis
info@isquaredcapital.com
Source : I Squared Capital


